Cargando…
Theranostic Tripartite Cancer Terminator Virus for Cancer Therapy and Imaging
SIMPLE SUMMARY: An optimum cancer therapeutic virus should embody unique properties, including an ability to: Selectively procreate and kill tumor but not normal cells; produce a secreted therapeutic molecule (with broad-acting anti-cancer effects on primary and distant metastatic cells because of p...
Autores principales: | Bhoopathi, Praveen, Pradhan, Anjan K., Maji, Santanu, Das, Swadesh K., Emdad, Luni, Fisher, Paul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922065/ https://www.ncbi.nlm.nih.gov/pubmed/33670594 http://dx.doi.org/10.3390/cancers13040857 |
Ejemplares similares
-
Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor
por: Pradhan, Anjan K., et al.
Publicado: (2022) -
Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter
por: Bhoopathi, Praveen, et al.
Publicado: (2022) -
Regulation of neuroblastoma migration, invasion and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin
por: Bhoopathi, Praveen, et al.
Publicado: (2019) -
Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking
por: Pradhan, Anjan K., et al.
Publicado: (2019) -
Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity
por: Bhoopathi, Praveen, et al.
Publicado: (2023)